Symbols / CAMP $4.49 +0.45% CAMP4 THERAPEUTICS CORPORATION

Healthcare • Biotechnology • United States • NGM
CAMP Chart
About

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 233.12M
Enterprise Value 124.56M Income -80.40M Sales 3.50M
Book/sh 0.92 Cash/sh 2.11 Dividend Yield —
Payout 0.00% Employees 48 IPO —
P/E — Forward P/E -6.35 PEG —
P/S 66.64 P/B 4.89 P/C —
EV/EBITDA -2.47 EV/Sales 35.61 Quick Ratio 7.07
Current Ratio 7.35 Debt/Eq 4.20 LT Debt/Eq —
EPS (ttm) -2.65 EPS next Y -0.71 EPS Growth —
Revenue Growth -46.60% Earnings 2026-03-05 16:00 ROA -33.18%
ROE -145.07% ROIC — Gross Margin 0.00%
Oper. Margin -36.71% Profit Margin 0.00% Shs Outstand 51.92M
Shs Float 29.21M Short Float 1.29% Short Ratio 1.25
Short Interest — 52W High 7.75 52W Low 1.30
Beta — Avg Volume 197.55K Volume 58.31K
Target Price $8.20 Recom Strong_buy Prev Close $4.47
Price $4.49 Change 0.45%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.20
Mean price target
2. Current target
$4.49
Latest analyst target
3. DCF / Fair value
$-7.16
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.49
Low
$5.00
High
$12.00
Mean
$8.20

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-02 main Leerink Partners Outperform → Outperform $9
2025-10-02 init Cantor Fitzgerald — → Overweight $7
2025-09-16 down JP Morgan Overweight → Neutral —
2025-09-15 main Piper Sandler Overweight → Overweight $12
2025-05-27 init Wedbush — → Outperform $8
2024-11-05 init William Blair — → Outperform —
2024-11-05 init Leerink Partners — → Outperform $17
2024-11-05 init JP Morgan — → Overweight $23
2024-11-05 init Piper Sandler — → Overweight $18
News
RSS: Latest CAMP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-11 YOUNG RICHARD A Director — 15,151 $2.78 $42,120
2025-09-11 NASHAT AMIR H. Director and Beneficial Owner of more than 10% of a Class of Security — 1,307,189 $2.79 $3,647,057
2025-09-11 POLARIS MANAGEMENT CO. VII, L.L.C Beneficial Owner of more than 10% of a Class of Security — 1,307,189 $2.79 $3,647,057
2025-09-11 MARICICH YURI M.D. Officer — 6,060 $2.79 $16,907
2025-09-11 5AM PARTNERS VI, LLC Beneficial Owner of more than 10% of a Class of Security — 2,941,176 $2.78 $8,176,469
2025-09-11 MANDEL-BREHM JOSH Chief Executive Officer — 6,060 $2.79 $16,907
2025-09-11 GOLD KELLY Chief Financial Officer — 6,060 $2.79 $16,907
2025-09-11 SCHWAB ANDREW J. Director and Beneficial Owner of more than 10% of a Class of Security — 2,941,176 $2.78 $8,176,469
2024-10-15 HOLTZMAN STEVEN H Director — 8,917 — —
2024-10-15 SCHWAB ANDREW J. Director and Beneficial Owner of more than 10% of a Class of Security — 2,018,825 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3.50
+436.50%
0.65
+86.29%
0.35
0.00
Operating Revenue
3.50
+436.50%
0.65
+86.29%
0.35
0.00
Operating Expense
55.56
+3.38%
53.74
+2.89%
52.23
+16.06%
45.00
Research And Development
38.20
-1.58%
38.82
-4.43%
40.62
+16.81%
34.77
Selling General And Administration
17.36
+16.31%
14.92
+28.50%
11.61
+13.52%
10.23
General And Administrative Expense
17.36
+16.31%
14.92
+28.50%
11.61
+13.52%
10.23
Salaries And Wages
8.35
-0.17%
8.37
+21.07%
6.91
+28.47%
5.38
Other Gand A
9.01
+37.33%
6.56
-43.53%
11.61
+139.34%
4.85
Total Expenses
55.56
+3.38%
53.74
+2.89%
52.23
+16.06%
45.00
Operating Income
-52.06
+1.93%
-53.09
-2.33%
-51.88
-15.28%
-45.00
Total Operating Income As Reported
-52.55
+1.00%
-53.09
-2.33%
-51.88
-15.28%
-45.00
EBITDA
-50.42
+1.89%
-51.39
-2.37%
-50.20
-13.78%
-44.12
Normalized EBITDA
-20.10
+60.89%
-51.39
-2.37%
-50.20
-13.78%
-44.12
Reconciled Depreciation
1.64
-3.36%
1.70
+1.07%
1.68
+91.12%
0.88
EBIT
-52.06
+1.93%
-53.09
-2.33%
-51.88
-15.28%
-45.00
Total Unusual Items
-30.32
0.00
—
—
Total Unusual Items Excluding Goodwill
-30.32
0.00
—
—
Special Income Charges
-0.49
0.00
—
—
Impairment Of Capital Assets
0.49
0.00
—
—
Net Income
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Pretax Income
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Net Non Operating Interest Income Expense
2.17
+63.46%
1.33
-52.64%
2.81
+210.62%
0.90
Net Interest Income
2.17
+63.46%
1.33
-52.64%
2.81
+210.62%
0.90
Interest Income Non Operating
2.17
+63.46%
1.33
-52.64%
2.81
+210.62%
0.90
Interest Income
2.17
+63.46%
1.33
-52.64%
2.81
+210.62%
0.90
Other Income Expense
-30.52
-92372.73%
-0.03
+85.00%
-0.22
-131.58%
-0.10
Other Non Operating Income Expenses
-0.19
-481.82%
-0.03
+85.00%
-0.22
-131.58%
-0.10
Gain On Sale Of Security
-29.83
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Net Income From Continuing Operation Net Minority Interest
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Net Income From Continuing And Discontinued Operation
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Net Income Continuous Operations
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Normalized Income
-50.08
+3.31%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Net Income Common Stockholders
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Diluted EPS
—
-11.04
-171.57%
-4.07
-11.54%
-3.64
Basic EPS
—
-11.04
-171.57%
-4.07
-11.54%
-3.64
Basic Average Shares
—
4.69
-61.32%
12.12
+0.00%
12.12
Diluted Average Shares
—
4.69
-61.32%
12.12
+0.00%
12.12
Diluted NI Availto Com Stockholders
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
117.81
+50.44%
78.31
+42.52%
54.95
-46.42%
102.55
Current Assets
114.09
+71.87%
66.38
+65.90%
40.01
-52.60%
84.41
Cash Cash Equivalents And Short Term Investments
109.52
+71.02%
64.04
+66.86%
38.38
-53.86%
83.19
Cash And Cash Equivalents
109.52
+71.02%
64.04
+66.86%
38.38
-53.86%
83.19
Receivables
0.15
+43.52%
0.11
-75.57%
0.44
-34.81%
0.68
Other Receivables
0.15
—
—
—
Taxes Receivable
0.00
-100.00%
0.11
-75.57%
0.44
-34.81%
0.68
Prepaid Assets
2.73
+35.06%
2.02
+114.06%
0.95
+181.55%
0.34
Restricted Cash
1.35
0.00
—
—
Other Current Assets
0.34
+62.09%
0.21
-13.88%
0.24
+19.51%
0.20
Total Non Current Assets
3.71
-68.86%
11.92
-20.15%
14.93
-17.68%
18.14
Net PPE
2.82
-72.63%
10.30
-22.61%
13.31
-20.76%
16.80
Gross PPE
10.57
-36.08%
16.53
-7.20%
17.81
-10.18%
19.83
Accumulated Depreciation
-7.75
-24.33%
-6.23
-38.31%
-4.50
-48.24%
-3.04
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.46
-2.08%
1.49
+2.12%
1.46
+3.47%
1.41
Other Properties
4.59
-56.41%
10.52
-11.10%
11.83
-14.88%
13.90
Leases
4.52
+0.00%
4.52
+0.00%
4.52
+0.00%
4.52
Other Non Current Assets
0.89
-44.95%
1.62
+0.00%
1.62
+20.65%
1.35
Total Liabilities Net Minority Interest
70.10
+362.34%
15.16
-91.51%
178.68
-0.78%
180.08
Current Liabilities
15.51
+61.64%
9.60
+22.94%
7.81
-1.75%
7.95
Payables And Accrued Expenses
3.08
+28.73%
2.40
-0.50%
2.41
-36.64%
3.80
Payables
0.18
-84.96%
1.21
+16.12%
1.04
-51.56%
2.15
Accounts Payable
0.18
-84.96%
1.21
+16.12%
1.04
-51.56%
2.15
Current Accrued Expenses
2.90
+144.81%
1.19
-13.19%
1.36
-17.17%
1.65
Pensionand Other Post Retirement Benefit Plans Current
2.64
-15.08%
3.11
+60.61%
1.94
+9.00%
1.78
Current Debt And Capital Lease Obligation
0.29
-90.45%
2.99
-2.09%
3.06
+29.03%
2.37
Current Capital Lease Obligation
0.29
-90.45%
2.99
-2.09%
3.06
+29.03%
2.37
Current Deferred Liabilities
9.39
+2338.18%
0.39
0.00
—
Current Deferred Revenue
9.39
+2338.18%
0.39
0.00
—
Other Current Liabilities
0.12
-83.73%
0.71
+76.05%
0.41
+56.37%
0.26
Total Non Current Liabilities Net Minority Interest
54.59
+880.95%
5.57
-96.74%
170.87
-0.73%
172.13
Long Term Debt And Capital Lease Obligation
1.69
-69.27%
5.49
-36.39%
8.63
-13.87%
10.03
Long Term Capital Lease Obligation
1.69
-69.27%
5.49
-36.39%
8.63
-13.87%
10.03
Non Current Deferred Liabilities
8.11
0.00
—
—
Non Current Deferred Revenue
8.11
0.00
—
—
Other Non Current Liabilities
0.03
-59.72%
0.07
-17.24%
0.09
+328.95%
-0.04
Preferred Securities Outside Stock Equity
—
0.00
-100.00%
162.15
+0.00%
162.15
Stockholders Equity
47.70
-24.45%
63.14
+151.03%
-123.73
-59.59%
-77.53
Common Stock Equity
47.70
-24.45%
63.14
+151.03%
-123.73
-59.59%
-77.53
Capital Stock
0.01
+200.00%
0.00
+100.00%
0.00
+0.00%
0.00
Common Stock
0.01
+200.00%
0.00
+100.00%
0.00
+0.00%
0.00
Share Issued
51.90
+157.44%
20.16
+3.36%
19.51
+0.00%
19.51
Ordinary Shares Number
51.90
+157.44%
20.16
+3.36%
19.51
+0.00%
19.51
Additional Paid In Capital
339.85
+23.63%
274.89
+658.73%
36.23
+9.33%
33.14
Retained Earnings
-292.16
-37.97%
-211.75
-32.38%
-159.96
-44.54%
-110.67
Total Equity Gross Minority Interest
47.70
-24.45%
63.14
+151.03%
-123.73
-59.59%
-77.53
Total Capitalization
47.70
-24.45%
63.14
+151.03%
-123.73
-59.59%
-77.53
Working Capital
98.58
+73.60%
56.78
+76.32%
32.21
-57.88%
76.46
Invested Capital
47.70
-24.45%
63.14
+151.03%
-123.73
-59.59%
-77.53
Total Debt
1.97
-76.74%
8.49
-27.42%
11.69
-5.66%
12.39
Capital Lease Obligations
1.97
-76.74%
8.49
-27.42%
11.69
-5.66%
12.39
Net Tangible Assets
47.70
-24.45%
63.14
+151.03%
-123.73
-59.59%
-77.53
Tangible Book Value
47.70
-24.45%
63.14
+151.03%
-123.73
-59.59%
-77.53
Derivative Product Liabilities
44.76
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-29.55
+35.14%
-45.56
-3.19%
-44.16
-14.56%
-38.54
Cash Flow From Continuing Operating Activities
-29.55
+35.14%
-45.56
-3.19%
-44.16
-14.56%
-38.54
Net Income From Continuing Operations
-80.40
-55.25%
-51.79
-5.07%
-49.29
-11.54%
-44.19
Depreciation Amortization Depletion
1.64
-3.36%
1.70
+1.07%
1.68
+91.12%
0.88
Depreciation And Amortization
1.64
-3.36%
1.70
+1.07%
1.68
+91.12%
0.88
Other Non Cash Items
1.62
-11.41%
1.83
+0.66%
1.82
+7.69%
1.69
Stock Based Compensation
4.00
-0.84%
4.03
+38.70%
2.91
+111.11%
1.38
Asset Impairment Charge
0.49
0.00
—
—
Operating Gains Losses
30.09
—
—
—
Gain Loss On Investment Securities
29.83
—
—
—
Gain Loss On Sale Of PPE
0.26
0.00
—
—
Change In Working Capital
13.01
+1077.31%
-1.33
-4.89%
-1.27
-174.47%
1.70
Change In Prepaid Assets
-0.89
-24.89%
-0.71
-69.29%
-0.42
+33.33%
-0.63
Change In Payables And Accrued Expense
-0.22
-113.13%
1.70
+235.81%
-1.25
-138.83%
3.22
Change In Accrued Expense
0.81
-47.42%
1.53
+1225.74%
-0.14
-107.19%
1.89
Change In Payable
-1.03
-711.90%
0.17
+115.07%
-1.11
-183.77%
1.33
Change In Account Payable
-1.03
-711.90%
0.17
+115.07%
-1.11
-183.77%
1.33
Change In Other Working Capital
14.12
+708.84%
-2.32
-676.87%
0.40
+145.27%
-0.89
Investing Cash Flow
-0.24
+44.90%
-0.44
+34.96%
-0.68
+83.16%
-4.03
Cash Flow From Continuing Investing Activities
-0.24
+44.90%
-0.44
+34.96%
-0.68
+83.16%
-4.03
Net PPE Purchase And Sale
-0.24
+44.90%
-0.44
+34.96%
-0.68
+83.16%
-4.03
Purchase Of PPE
-0.28
+36.73%
-0.44
+34.96%
-0.68
+83.16%
-4.03
Sale Of PPE
0.04
0.00
—
—
Capital Expenditure
-0.28
+36.73%
-0.44
+34.96%
-0.68
+83.16%
-4.03
Financing Cash Flow
75.89
+5.90%
71.66
+23707.97%
0.30
-99.70%
100.16
Cash Flow From Continuing Financing Activities
75.89
+5.90%
71.66
+23707.97%
0.30
-99.70%
100.16
Net Issuance Payments Of Debt
-0.11
+69.51%
-0.36
-13.04%
-0.32
-246.24%
-0.09
Repayment Of Debt
-0.11
+69.51%
-0.36
-13.04%
-0.32
-246.24%
-0.09
Long Term Debt Payments
-0.11
+69.51%
-0.36
-13.04%
-0.32
-246.24%
-0.09
Net Long Term Debt Issuance
-0.11
+69.51%
-0.36
-13.04%
-0.32
-246.24%
-0.09
Net Common Stock Issuance
57.52
-24.67%
76.35
0.00
—
Proceeds From Stock Option Exercised
3.65
+3131.86%
0.11
-38.92%
0.18
+236.36%
0.06
Net Other Financing Charges
14.83
+434.08%
-4.44
-1113.70%
0.44
—
Changes In Cash
46.09
+79.64%
25.66
+157.62%
-44.53
-177.33%
57.59
Beginning Cash Position
65.66
+64.14%
40.00
-52.68%
84.54
+213.71%
26.95
End Cash Position
111.76
+70.20%
65.66
+64.14%
40.00
-52.68%
84.54
Free Cash Flow
-29.83
+35.15%
-46.00
-2.61%
-44.83
-5.32%
-42.57
Common Stock Issuance
57.52
-24.67%
76.35
0.00
—
Issuance Of Capital Stock
57.52
-24.67%
76.35
0.00
-100.00%
100.19
Net Preferred Stock Issuance
—
—
0.00
-100.00%
100.19
Preferred Stock Issuance
—
—
0.00
-100.00%
100.19
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category